185 related articles for article (PubMed ID: 31263780)
1. Crystal structure of human endothelin ET
Nagiri C; Shihoya W; Inoue A; Kadji FMN; Aoki J; Nureki O
Commun Biol; 2019; 2():236. PubMed ID: 31263780
[TBL] [Abstract][Full Text] [Related]
2. X-ray structures of endothelin ET
Shihoya W; Nishizawa T; Yamashita K; Inoue A; Hirata K; Kadji FMN; Okuta A; Tani K; Aoki J; Fujiyoshi Y; Doi T; Nureki O
Nat Struct Mol Biol; 2017 Sep; 24(9):758-764. PubMed ID: 28805809
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the binding of endothelin ETB selective ligands in human and rat heart.
Russell FD; Davenport AP
Br J Pharmacol; 1996 Oct; 119(4):631-6. PubMed ID: 8904635
[TBL] [Abstract][Full Text] [Related]
4. Discovery of IRL 3461: a novel and potent endothelin antagonist with balanced ETA/ETB affinity.
Sakaki J; Murata T; Yuumoto Y; Nakamura I; Trueh T; Pitterna T; Iwasaki G; Oda K; Yamamura T; Hayakawa K
Bioorg Med Chem Lett; 1998 Aug; 8(16):2241-6. PubMed ID: 9873521
[TBL] [Abstract][Full Text] [Related]
5. Crystal structures of human ET
Shihoya W; Izume T; Inoue A; Yamashita K; Kadji FMN; Hirata K; Aoki J; Nishizawa T; Nureki O
Nat Commun; 2018 Nov; 9(1):4711. PubMed ID: 30413709
[TBL] [Abstract][Full Text] [Related]
6. Expression and purification of an engineered human endothelin receptor B in a monomeric form.
Mishin AV; Luginina AP; Potapenko AP; Borshchevskiy VI; Katritch V; Edelweiss E; Okhrimenko IS; Gordeliy VI; Cherezov VG
Dokl Biochem Biophys; 2016 Mar; 467(1):157-61. PubMed ID: 27193723
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective synthesis of a novel and bifunctional endothelin antagonist, IRL 3630.
Sakaki J; Murata T; Yuumoto Y; Nakamura I; Hayakawa K
Bioorg Med Chem Lett; 1998 Aug; 8(16):2247-52. PubMed ID: 9873522
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of human endothelin ET
Izume T; Miyauchi H; Shihoya W; Nureki O
Biochem Biophys Res Commun; 2020 Jul; 528(2):383-388. PubMed ID: 32001000
[TBL] [Abstract][Full Text] [Related]
9. Acute pro-inflammatory actions of endothelin-1 in the guinea-pig lung: involvement of ETA and ETB receptors.
Filep JG; Fournier A; Földes-Filep E
Br J Pharmacol; 1995 May; 115(2):227-36. PubMed ID: 7670725
[TBL] [Abstract][Full Text] [Related]
10. Hybrid peptides constructed from RES-701-1, an endothelin B receptor antagonist, and endothelin; binding selectivity for endothelin receptors and their pharmacological activity.
Shibata K; Suzawa T; Ohno T; Yamada K; Tanaka T; Tsukuda E; Matsuda Y; Yamasaki M
Bioorg Med Chem; 1998 Dec; 6(12):2459-67. PubMed ID: 9925302
[TBL] [Abstract][Full Text] [Related]
11. Activation mechanism of endothelin ET
Shihoya W; Nishizawa T; Okuta A; Tani K; Dohmae N; Fujiyoshi Y; Nureki O; Doi T
Nature; 2016 Sep; 537(7620):363-368. PubMed ID: 27595334
[TBL] [Abstract][Full Text] [Related]
12. Membrane dynamics simulation and virtual screening reveals potential dual natural inhibitors of endothelin receptors for targeting glaucomatous condition.
Nagarajan H; Vetrivel U
Life Sci; 2021 Mar; 269():119082. PubMed ID: 33482184
[TBL] [Abstract][Full Text] [Related]
13. Dipeptide sulfonamides as endothelin ETA/ETB receptor antagonists.
Ksander GM; Shetty SS; DelGrande D; Balwierczak JL; Bruseo CW; Savage P; deJesus R; Yuan A; Webb RL; Jeng AY
Can J Physiol Pharmacol; 2002 May; 80(5):464-9. PubMed ID: 12056554
[TBL] [Abstract][Full Text] [Related]
14. Plasma- and cerebrospinal fluid-immunoreactive endothelin-1: effects of nonpeptide endothelin receptor antagonists with diverse affinity profiles for endothelin-A and endothelin-B receptors.
Willette RN; Sauermelch CF; Storer BL; Guiney S; Luengo JI; Xiang JN; Elliott JD; Ohlstein EH
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S149-57. PubMed ID: 9595425
[TBL] [Abstract][Full Text] [Related]
15. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.
Seo B; Oemar BS; Siebenmann R; von Segesser L; Lüscher TF
Circulation; 1994 Mar; 89(3):1203-8. PubMed ID: 8124808
[TBL] [Abstract][Full Text] [Related]
16. Cryo-EM structure of the endothelin-1-ET
Sano FK; Akasaka H; Shihoya W; Nureki O
Elife; 2023 Apr; 12():. PubMed ID: 37096326
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Critical Residues in the Extracellular and Transmembrane Domains of the Endothelin Type B Receptor for Propagation of the Endothelin-1 Signal.
Doi T; Kikuta K; Tani K
Biochemistry; 2020 May; 59(18):1718-1727. PubMed ID: 32343134
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart.
Peter MG; Davenport AP
Br J Pharmacol; 1996 Feb; 117(3):455-462. PubMed ID: 8821534
[TBL] [Abstract][Full Text] [Related]
19. Effects of human peptide endothelin-1 and two of its sterically unrestrained C-terminal fragments on coronaryvascular smooth muscle.
Drímal J; Drímal J; Orlický J; Janecek A; Kettmann V; Drímal D; Húzavová M
Gen Physiol Biophys; 2002 Mar; 21(1):3-14. PubMed ID: 12168722
[TBL] [Abstract][Full Text] [Related]
20. Endothelin ET
Vercauteren M; Trensz F; Pasquali A; Cattaneo C; Strasser DS; Hess P; Iglarz M; Clozel M
J Pharmacol Exp Ther; 2017 May; 361(2):322-333. PubMed ID: 28223322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
